Daniel Wilson to Humans
This is a "connection" page, showing publications Daniel Wilson has written about Humans.
Connection Strength
0.258
-
Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes. Expert Rev Clin Pharmacol. 2022 May; 15(5):501-513.
Score: 0.027
-
Machine learning to predict the source of campylobacteriosis using whole genome data. PLoS Genet. 2021 10; 17(10):e1009436.
Score: 0.026
-
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65.
Score: 0.017
-
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A. 2012 Mar 20; 109(12):4550-5.
Score: 0.013
-
Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged = 65 years by lipid-lowering medication use status. Postgrad Med. 2010 Sep; 122(5):142-9.
Score: 0.012
-
Rapid evolution and the importance of recombination to the gastroenteric pathogen Campylobacter jejuni. Mol Biol Evol. 2009 Feb; 26(2):385-97.
Score: 0.011
-
Tracing the source of campylobacteriosis. PLoS Genet. 2008 Sep 26; 4(9):e1000203.
Score: 0.010
-
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial. J Am Soc Nephrol. 2022 01; 33(1):225-237.
Score: 0.006
-
4,7-Disubstituted 7H-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus. Molecules. 2021 Jun 22; 26(13).
Score: 0.006
-
Discovery of Irreversible p97 Inhibitors. J Med Chem. 2019 03 14; 62(5):2814-2829.
Score: 0.005
-
6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. Eur J Med Chem. 2018 Aug 05; 156:652-665.
Score: 0.005
-
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H. Eur J Med Chem. 2018 Aug 05; 156:680-691.
Score: 0.005
-
Bayesian reconstruction of transmission within outbreaks using genomic variants. PLoS Comput Biol. 2018 04; 14(4):e1006117.
Score: 0.005
-
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. J Med Chem. 2017 06 22; 60(12):5045-5056.
Score: 0.005
-
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics. J Hypertens. 2017 05; 35 Suppl 1:S57-S63.
Score: 0.005
-
6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. Eur J Med Chem. 2017 Mar 10; 128:168-179.
Score: 0.005
-
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. J Med Chem. 2016 07 14; 59(13):6136-48.
Score: 0.004
-
Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H. J Med Chem. 2016 05 26; 59(10):5051-62.
Score: 0.004
-
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors. J Med Chem. 2016 Apr 14; 59(7):2928-41.
Score: 0.004
-
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations. J Med Chem. 2016 Mar 24; 59(6):2648-59.
Score: 0.004
-
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Apr 15; 117(8):1199-205.
Score: 0.004
-
Rapid host switching in generalist Campylobacter strains erodes the signal for tracing human infections. ISME J. 2016 Mar; 10(3):721-9.
Score: 0.004
-
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach. J Med Chem. 2014 Oct 23; 57(20):8340-57.
Score: 0.004
-
Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014 Oct; 45(10):2974-82.
Score: 0.004
-
Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013 Sep 26; 369(13):1195-205.
Score: 0.004
-
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15; 109(12):1761-6.
Score: 0.003
-
Utilizing a combination of molecular and spatial tools to assess the effect of a public health intervention. Prev Vet Med. 2011 Dec 01; 102(3):242-53.
Score: 0.003
-
Evolution of an agriculture-associated disease causing Campylobacter coli clade: evidence from national surveillance data in Scotland. PLoS One. 2010 Dec 15; 5(12):e15708.
Score: 0.003
-
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure. Bioorg Med Chem. 2010 Aug 15; 18(16):5950-64.
Score: 0.003
-
Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis. J Med Chem. 2010 Jun 24; 53(12):4768-78.
Score: 0.003
-
Spatio-temporal epidemiology of Campylobacter jejuni enteritis, in an area of Northwest England, 2000-2002. Epidemiol Infect. 2010 Oct; 138(10):1384-90.
Score: 0.003
-
Molecular and spatial epidemiology of human campylobacteriosis: source association and genotype-related risk factors. Epidemiol Infect. 2010 Oct; 138(10):1372-83.
Score: 0.003
-
Assigning the source of human campylobacteriosis in New Zealand: a comparative genetic and epidemiological approach. Infect Genet Evol. 2009 Dec; 9(6):1311-9.
Score: 0.003
-
Broad-scale recombination patterns underlying proper disjunction in humans. PLoS Genet. 2009 Sep; 5(9):e1000658.
Score: 0.003
-
Campylobacter genotyping to determine the source of human infection. Clin Infect Dis. 2009 Apr 15; 48(8):1072-8.
Score: 0.003
-
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis. 2009 May; 53(5):741-50.
Score: 0.003
-
Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis. J Med Chem. 2008 Dec 11; 51(23):7495-507.
Score: 0.003
-
Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. Am J Hypertens. 2009 Feb; 22(2):137-44.
Score: 0.003
-
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc. 2008 Aug; 83(8):870-9.
Score: 0.003
-
Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase. Bioorg Med Chem. 2008 Aug 01; 16(15):7462-9.
Score: 0.003
-
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008 Apr 15; 51(15):1448-54.
Score: 0.003
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1131-9.
Score: 0.002
-
Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor. Bioorg Med Chem Lett. 2007 Jun 01; 17(11):3152-5.
Score: 0.002
-
Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics. 2006 Nov; 174(3):1441-53.
Score: 0.002
-
Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol Biol. 2006 Mar 23; 6:28.
Score: 0.002
-
The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol. 2005 Mar; 22(3):562-9.
Score: 0.002